Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Crawford & Company B | CRD-B | Jan 14, 2025 | 11.35 | +4.80 |
Creative Global Technology | CGTL | Jan 14, 2025 | 5.85 | 0.00 |
Creative Media & Community Trust | CMCT | Jan 14, 2025 | 0.99 | +4.16 |
Creative Medical Technology | CELZ | Jan 14, 2025 | 2.15 | -3.73 |
Creative Realities | CREX | Jan 14, 2025 | 2.53 | +0.40 |
Credicorp | BAP | Jan 14, 2025 | 187.83 | +4.33 |
Credit Acceptance | CACC | Jan 14, 2025 | 461.98 | +2.29 |
Credit Enhanced Corts Trust Aon Capital A | KTN | Jan 14, 2025 | 26.30 | +0.01 |
Credit Suisse Ag | SLVO | Jan 14, 2025 | 76.10 | +1.41 |
Credit Suisse Ag | GLDI | Jan 14, 2025 | 156.76 | +0.75 |
Credit Suisse Asset Management Income Fund | CIK | Jan 14, 2025 | 2.90 | -0.68 |
Credit Suisse Gold Shares Covered Calls ETN | USOI | Jan 14, 2025 | 67.34 | -0.16 |
Credit Suisse High Yield Bond Fund | DHY | Jan 14, 2025 | 2.14 | +0.94 |
Credo Technology | CRDO | Jan 14, 2025 | 69.39 | +0.51 |
Crescent Capital BDC | CCAP | Jan 14, 2025 | 19.06 | +2.36 |
Crescent Energy | CRGY | Jan 14, 2025 | 16.59 | +1.10 |
Cresud A ADR | CRESY | Jan 14, 2025 | 13.21 | +4.02 |
Crexendo | CXDO | Jan 14, 2025 | 5.17 | +0.78 |
CRH | CRH | Jan 14, 2025 | 92.69 | +1.25 |
Cricut A | CRCT | Jan 14, 2025 | 5.75 | +1.59 |
Crinetics Pharmaceuticals | CRNX | Jan 14, 2025 | 35.62 | -8.62 |
CRISPR Therapeutics | CRSP | Jan 14, 2025 | 38.36 | -1.26 |
Criteo ADR | CRTO | Jan 14, 2025 | 37.23 | +0.51 |
Critical Metals | CRML | Jan 14, 2025 | 8.28 | +0.36 |
Crocs | CROX | Jan 14, 2025 | 105.12 | -0.61 |
Cronos Group | CRON | Jan 14, 2025 | 1.95 | 0.00 |
Cross Country Healthcare | CCRN | Jan 14, 2025 | 18.16 | -0.16 |
Cross Timbers Royalty Royalty Trust | CRT | Jan 14, 2025 | 10.23 | +0.89 |
CrossAmerica Partners LP Unit | CAPL | Jan 14, 2025 | 22.45 | +0.09 |
CrossFirst Bankshares | CFB | Jan 14, 2025 | 14.61 | +2.67 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.